5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)

Condition:   Oligometastatic Prostate Cancer Interventions:   Radiation: Hypofractionated external beam radiotherapy;   Radiation: High dose rate brachytherapy;   Radiation: Permanent seed implant;   Radiation: Stereotactic body radiotherapy Sponsor:   British Columbia Cancer Agency Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials